Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	89.82	127.67	135.55	66.33	77.62	76.19
Short-Term Investments	232.94	255.67	232.67	365.34	145.92	364.51
Cash & Short-Term Investments	322.76	383.33	368.22	431.67	223.54	440.7
Cash Growth	-21.42%	4.10%	-14.70%	93.11%	-49.28%	59.69%
Accounts Receivable	61.82	53.98	41.12	31.06	27.63	26.2
Other Receivables	-	-	14	15.8	1.4	1.3
Receivables	61.82	53.98	55.12	46.86	29.03	27.5
Inventory	14.37	12.41	7.73	6.1	4.99	4.91
Prepaid Expenses	8.55	9.49	4.32	14.62	8.92	5.4
Other Current Assets	31	12.39	23.24	-	-	-
Total Current Assets	438.5	471.6	458.64	499.25	266.46	478.5
Property, Plant & Equipment	7.69	8.01	0.32	1.78	1.52	4.18
Long-Term Investments	248.04	219.83	57.18	4.95	112.28	36.2
Long-Term Deferred Tax Assets	144.45	130.91	90.61	61.47	27.46	31.6
Other Long-Term Assets	7.78	10.19	14.79	15.99	16.05	21.25
Total Assets	846.46	840.55	621.52	583.43	423.76	571.73
Accounts Payable	27.95	15.38	17.4	11.98	6.91	10.55
Accrued Expenses	110.11	122.11	70.49	44.52	39.3	34.69
Current Portion of Leases	0.98	0.83	0.15	1.14	0.53	2.05
Current Income Taxes Payable	-	0.19	1.81	0.09	0.51	-
Other Current Liabilities	4.03	2.27	14.65	14.76	0.3	0.2
Total Current Liabilities	143.07	140.77	104.51	72.49	47.54	47.49
Long-Term Leases	5.85	6.11	-	-	-	0.5
Other Long-Term Liabilities	14.25	14.08	10.31	9.1	0.41	0.4
Total Liabilities	163.17	160.96	114.81	81.59	47.95	48.39
Common Stock	0.14	0.14	0.13	0.13	0.13	0.12
Additional Paid-In Capital	862.87	832.11	738.52	662.34	591.35	516.14
Retained Earnings	564.28	543.74	402.53	296.39	194.97	82.46
Treasury Stock	-744.69	-696.17	-635.08	-456.15	-410.41	-75.8
Comprehensive Income & Other	0.69	-0.22	0.61	-0.87	-0.23	0.42
Shareholders' Equity	683.29	679.59	506.71	501.84	375.81	523.34
Total Liabilities & Equity	846.46	840.55	621.52	583.43	423.76	571.73
Total Debt	6.84	6.94	0.15	1.14	0.53	2.55
Net Cash (Debt)	563.97	596.23	425.25	435.48	335.29	474.34
Net Cash Growth	25.06%	40.21%	-2.35%	29.88%	-29.32%	52.10%
Net Cash Per Share	4.86	5.25	3.81	3.76	2.66	3.82
Filing Date Shares Outstanding	106.04	105.5	103.52	107.9	105.96	117.31
Total Common Shares Outstanding	105.98	105.11	103.41	107.84	105.94	116.74
Working Capital	295.44	330.83	354.13	426.76	218.92	431.01
Book Value Per Share	6.45	6.47	4.90	4.65	3.55	4.48
Tangible Book Value	683.29	679.59	506.71	501.84	375.81	523.34
Tangible Book Value Per Share	6.45	6.47	4.90	4.65	3.55	4.48
Machinery	-	-	-	-	1.16	0.81
Leasehold Improvements	-	-	-	-	1.26	1.23

Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q